Travere Therapeutics (TVTX) EBIT Margin (2014 - 2026)
Travere Therapeutics (TVTX) posted EBIT Margin of 2.33% for Q2 2026, up 13.38 percentage points from -11.05% a year earlier and up 31.35 percentage points from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) EBIT Margin (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT Margin at Travere Therapeutics was -6.84%, up 44.74 percentage points year-over-year; for FY2025, it was -12.80%, up 126.08 percentage points from FY2024.
- Annual EBIT Margin has increased for four consecutive years, with a five-year change of +76.03 percentage points (FY2020 to FY2025).
- In prior years, Travere Therapeutics' EBIT Margin was -138.88% in FY2024 (+128.37 pp), -267.24% in FY2023 (+24.93 pp), -292.17% in FY2022 (+1369.70 pp) and -1661.88% in FY2021 (-1573.05 pp).
- Quarterly EBIT Margin has run from a low of -707.08% in Q4 2021 to a high of 15.12% in Q3 2025 over five years.
- On a year-over-year basis, EBIT Margin has increased in each of the last nine quarters, with an average year-over-year change of +110.47 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q4 2022, with a gain of 411.57 percentage points; the weakest was Q4 2021, with a drop of 474.55 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was -29.02% (Q1 2026), -25.00% (Q4 2025) and 15.12% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Travere Therapeutics | 5.80 Bn | 5.40 Bn | 167.41 Mn | 2.33% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.33% |
| Mar 31, 2026 | -29.02% |
| Dec 31, 2025 | -25.00% |
| Sep 30, 2025 | 15.12% |
| Jun 30, 2025 | -11.05% |
| Mar 31, 2025 | -52.21% |
| Dec 31, 2024 | -81.21% |
| Sep 30, 2024 | -89.27% |
| Jun 30, 2024 | -125.11% |
| Mar 31, 2024 | -336.53% |
| Dec 31, 2023 | -209.13% |
| Sep 30, 2023 | -249.59% |
| Jun 30, 2023 | -322.87% |
| Mar 31, 2023 | -315.23% |
| Dec 31, 2022 | -295.52% |
| Sep 30, 2022 | -294.23% |
| Jun 30, 2022 | -274.24% |
| Mar 31, 2022 | -307.45% |
| Dec 31, 2021 | -707.08% |
| Sep 30, 2021 | -46.49% |
API Access
Travere Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();